These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35064090)

  • 21. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.
    Rossi S; Shimizu M; Barbarotto E; Nicoloso MS; Dimitri F; Sampath D; Fabbri M; Lerner S; Barron LL; Rassenti LZ; Jiang L; Xiao L; Hu J; Secchiero P; Zauli G; Volinia S; Negrini M; Wierda W; Kipps TJ; Plunkett W; Coombes KR; Abruzzo LV; Keating MJ; Calin GA
    Blood; 2010 Aug; 116(6):945-52. PubMed ID: 20393129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.
    Chapiro E; Lesty C; Gabillaud C; Durot E; Bouzy S; Armand M; Le Garff-Tavernier M; Bougacha N; Struski S; Bidet A; Laharanne E; Barin C; Veronese L; Prié N; Eclache V; Gaillard B; Michaux L; Lefebvre C; Gaillard JB; Terré C; Penther D; Bastard C; Nadal N; Fert-Ferrer S; Auger N; Godon C; Sutton L; Tournilhac O; Susin SA; Nguyen-Khac F;
    Am J Hematol; 2018 Mar; 93(3):375-382. PubMed ID: 29194741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia.
    Balogh Z; Reiniger L; Rajnai H; Csomor J; Szepesi A; Balogh A; Deák L; Gagyi E; Bödör C; Matolcsy A
    Leuk Lymphoma; 2011 Jun; 52(6):1080-4. PubMed ID: 21417824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis.
    Athanasiadou A; Stamatopoulos K; Tsompanakou A; Gaitatzi M; Kalogiannidis P; Anagnostopoulos A; Fassas A; Tsezou A
    Cancer Genet Cytogenet; 2006 Jul; 168(2):109-19. PubMed ID: 16843100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
    Rodríguez AE; Hernández JÁ; Benito R; Gutiérrez NC; García JL; Hernández-Sánchez M; Risueño A; Sarasquete ME; Fermiñán E; Fisac R; de Coca AG; Martín-Núñez G; de Las Heras N; Recio I; Gutiérrez O; De Las Rivas J; González M; Hernández-Rivas JM
    PLoS One; 2012; 7(11):e48485. PubMed ID: 23152777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
    Greipp PT; Smoley SA; Viswanatha DS; Frederick LS; Rabe KG; Sharma RG; Slager SL; Van Dyke DL; Shanafelt TD; Tschumper RC; Zent CS
    Br J Haematol; 2013 Nov; 163(3):326-33. PubMed ID: 24032430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
    Fabris S; Scarciolla O; Morabito F; Cifarelli RA; Dininno C; Cutrona G; Matis S; Recchia AG; Gentile M; Ciceri G; Ferrarini M; Ciancio A; Mannarella C; Neri A; Fragasso A
    Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study.
    Lai YY; Huang XJ
    Chin Med J (Engl); 2011 Aug; 124(16):2417-22. PubMed ID: 21933580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go.
    Puiggros A; Blanco G; Espinet B
    Biomed Res Int; 2014; 2014():435983. PubMed ID: 24967369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular cytogenetic characteristics of chronic lymphocytic leukemia].
    Xu W; Li JY; Pan JL; Qiu HR; Shen YF; Xiao B; Chen LJ; Wu YF; Sheng RL; Xue YQ
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):349-52. PubMed ID: 17044998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
    Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
    Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.
    Reddy KS
    Br J Haematol; 2006 Mar; 132(6):705-22. PubMed ID: 16487171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
    Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
    Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytogenetic markers in chronic lymphocytic leukemia].
    Nguyen-Khac F
    Ann Biol Clin (Paris); 2010; 68(3):273-6. PubMed ID: 20478769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
    Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
    Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia.
    Karhu R; Tobin G; Thunberg U; Vilpo L; Sundström C; Knuutila S; Rosenquist R; Vilpo J
    Genes Chromosomes Cancer; 2003 Aug; 37(4):417-20. PubMed ID: 12800154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
    Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
    Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.